Advanced Biomed (ADVB) Beginning Cash Balance (2025)

Advanced Biomed (ADVB) posted Beginning Cash Balance of $6715.0 for Q4 2025, down 40.18% sequentially from $11226.0 in Q3 2025.

Advanced Biomed (ADVB) Beginning Cash Balance (2025) Analysis & Trends

Advanced Biomed (ADVB) has 1 years of Beginning Cash Balance data on file, last reported at $6715.0 in Q4 2025.

Quarterly Beginning Cash Balance changed N/A year-over-year to $6715.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $304309.0 (changed N/A YoY) and the FY2025 annual result came in at $237552.0, changed N/A from the prior year.
Beginning Cash Balance declined to $6715.0 in Q4 2025 per ADVB's latest filing, from $11226.0 in the prior quarter.
The five-year high for Beginning Cash Balance was $236368.0 in Q2 2025, with the low at $6715.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Advanced Biomed	6.22 Mn	6.22 Mn	-

Download Data